Profile
Client: Leading global contract manufacturer
Area: API Synthesis
Market: Europe (EMEA)
IDrug
assignment
»  The API synthesis process for an orphan drug that our client had developed lead to several unknown interfering impurities.
»  IDrug was contracted to identify these impurities to support the client in avoiding their formation.
Result
»  IDrug conducted a structure determination of undesirable impurities using GC/MS, HPLC/MS/MS and NMR.
»  2 weeks from first discussions with client to final delivery of structure determination
»  Results were the basis for the optimizing the current synthesis process.